These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27197582)

  • 21. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
    Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Sotoca A; Pérez-Ruiz E; Lanzós E
    Am J Clin Oncol; 2011 Aug; 34(4):395-400. PubMed ID: 20859196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
    N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: a prospective randomized pilot study.
    Garipağaoğlu M; Kayikçioğlu F; Köse MF; Adli M; Gülkesen KH; Koçak Z; Tulunay G
    Br J Radiol; 2004 Jul; 77(919):581-7. PubMed ID: 15238405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Sugiyama T; Nishida T; Kumagai S; Nishio S; Fujiyoshi K; Okura N; Yakushiji M; Hiura M; Umesaki N
    Br J Cancer; 1999 Sep; 81(1):95-8. PubMed ID: 10487618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
    J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
    Zanaboni F; Grijuela B; Giudici S; Cormio G; Babilonti L; Ghezzi F; Giorda G; Scambia G; Franchi M; Lorusso M; Ditto A; Lorusso D; Raspagliesi F
    Eur J Cancer; 2013 Mar; 49(5):1065-72. PubMed ID: 23151423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.
    Goedhals L; Falkson G; Smith BL; Falkson CI; Gasmi J; Lategan A; Burillon JP; His P
    Anticancer Res; 2005; 25(3c):2489-92. PubMed ID: 16080481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.
    Katanyoo K; Sanguanrungsirikul S; Manusirivithaya S
    Gynecol Oncol; 2012 May; 125(2):292-6. PubMed ID: 22293041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.